Josef H. Vormoor

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Correction: Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective.

Correction: Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: June 19, 2026

Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective.

Training European Health Care Providers in Adolescent and Young Adult (AYA) Oncology: The Joint Action Networks of Expertise (JANE) on AYA with Cancer Perspective.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: March 19, 2026

A Europe-wide provider perspective of healthcare services for adolescent and young adult patients with haematological conditions: a survey from the Adolescent and Young Adult Taskforce of the European Hematology Association.

A Europe-wide provider perspective of healthcare services for adolescent and young adult patients with haematological conditions: a survey from the Adolescent and Young Adult Taskforce of the European Hematology Association.

Journal: EClinicalMedicine

Published: October 18, 2025

Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia.

Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia.

Journal: Blood

Published: February 25, 2025

M&M: an RNA-seq based pan-cancer classifier for paediatric tumours.

M&M: an RNA-seq based pan-cancer classifier for paediatric tumours.

Journal: EBioMedicine

Published: August 30, 2024

Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.

Journal: Cancer discovery

Published: June 27, 2024

Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey.

Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey.

Journal: Tumori

Published: July 24, 2023

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia.

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia.

Journal: Cancers

Published: November 28, 2022

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial.

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial.

Journal: BMJ open

Published: March 05, 2022

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.

Journal: Haematologica

Published: January 06, 2022

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.

Journal: Blood

Published: December 03, 2021

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.

hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.

Journal: Cell reports. Medicine

Published: November 23, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026